Cargando…
Tumors Acquire Inhibitor of Apoptosis Protein (IAP)-mediated Apoptosis Resistance through Altered Specificity of Cytosolic Proteolysis
Many tumors overexpress members of the inhibitor of apoptosis protein (IAP) family. IAPs contribute to tumor cell apoptosis resistance by the inhibition of caspases, and are degraded by the proteasome to allow further progression of apoptosis. Here we show that tumor cells can alter the specificity...
Autores principales: | Hong, Xu, Lei, Lu, Glas, Rickard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193958/ https://www.ncbi.nlm.nih.gov/pubmed/12810691 http://dx.doi.org/10.1084/jem.20020801 |
Ejemplares similares
-
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
por: Berthelet, Jean, et al.
Publicado: (2013) -
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs
por: Verhagen, Anne M, et al.
Publicado: (2001) -
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress
por: Marivin, Arthur, et al.
Publicado: (2012) -
Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer
por: Vaux, David L
Publicado: (2009) -
IAPs on the move: role of inhibitors of apoptosis proteins in cell migration
por: Oberoi-Khanuja, T K, et al.
Publicado: (2013)